MAGEB17 antisense RNA 1 (MAGEB17-AS1)

MAGEB17 antisense RNA 1 (MAGEB17-AS1 or lnc-AP1S2-2) is a long noncoding RNA gene annotated in the human genome. As an antisense transcript, it is transcribed from the opposite DNA strand relative to the MAGEB17 gene. No experimentally validated biological function, disease association, or drug interaction has been described for this RNA in currently available scientific literature and databases. It is not recognized as a functional therapeutic target, and there is no evidence connecting it to a molecular pathway, disease role, or clinical biomarker utility. Databases such as GeneCards list MAGEB17-AS1 as a predicted/annotated noncoding RNA gene. There are no primary literature or experimental studies characterizing its function, relevance to disease, or pharmacological tractability. Unlike better-studied antisense RNAs and lncRNAs with established biological roles, MAGEB17-AS1 lacks evidence for gene regulatory or pathological functions. It is not recognized in expert-reviewed disease or drug-target databases and does not appear in curated lncRNA functional resources. The only available information regards its sequence annotation and genomic context; there is no evidence justifying its classification as a therapeutic or molecular target. This entry is likely included in some databases due to automated lncRNA gene prediction pipelines and nominal annotation as an "antisense RNA gene," not because of verified functional data. In summary, there is no substantive scientific evidence that MAGEB17 antisense RNA 1 (MAGEB17-AS1/lnc-AP1S2-2) is a molecular target or has known biological or disease relevance. Any attempt to ascribe function or therapeutic context to this RNA, given current evidence, would be speculative and unsupported by existing data.

Other names

lnc-AP1S2-2MAGEB17-AS1